Clin2
NCT06729541Possibly a fitRecruiting

Precision treatments for common mental disorders

Depression - Major Depressive DisorderSchizophrenia DisordersBipolar Disorder (BD)

Part of Mental health clinical trials.

This study is developing more personalized treatments for schizophrenia, depression, or bipolar disorder. It may help find the best treatment approach for your specific situation.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
600 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old
  • You have been diagnosed with schizophrenia, depression, or bipolar disorder
  • Your symptoms are at least moderate in severity (based on a standard rating scale)
  • You are able to read, understand, and complete questionnaires and treatments
  • You do not have severe suicidal thoughts, unstable physical illness, or certain other conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07738497Not yet recruiting
Finding biomarkers to personalize depression treatment

This trial is looking for people with major depression to study how genes and other markers might help doctors choose the best medication. The goal is to make depression treatment more precise and effective.

NCT07480486Not yet recruiting
Genetic testing for better antidepressant choice in depression

This study looks at whether a genetic test can help choose the best antidepressant for you. It aims to make treatment more personalized and effective for people with depression.

Rabat, Rabat-Salé-Kénitra
NCT07649993Not yet recruiting
Gene Expression Study in Psychiatric Conditions

This research study examines how certain genes are expressed (turned on or off) in people with psychiatric conditions like bipolar disorder, depression, panic disorder, OCD, or schizophrenia. The study compares gene expression in patients with these conditions to healthy volunteers to better understand what happens at a biological level.

Catania, Sicily
NCT06641726Recruiting
Global database linking genetics and health records for mental illness

This trial is building a research database that combines genetic information and long-term health data to improve personalized treatment for serious mental illness. You may be eligible if you have been diagnosed or treated for depression, bipolar disorder, schizophrenia, or dementia.

Oxford, Oxford
NCT07586150Not yet recruiting
Personalized Treatment for Serious Mental Illness

This study tests whether combining medicine adjustments, lifestyle changes (like diet and exercise), and optional brain stimulation can help people with schizophrenia, bipolar disorder, or depression feel better and function more independently. It may include a weight-loss medication if you're overweight or obese.

Vienna
NCT07373470Not yet recruiting
Pharmacist help with depression meds using your DNA

This trial tests whether a pharmacist can use your genetic information to better manage your depression medications. It may help find the right drug or dose for you.

Pittsburgh, Pennsylvania

Hear when a new Depression - Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.